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PENGESANAN Salmonella enterica subsp. enterica serovar Typhi DARIPADA 
SAMPEL KOLESISTEKTOMI MELALUI KONVENSIONAL, SEROLOGI 




Salmonella enterica subsp. enterica serovars Typhi (S. Typhi) adalah agen 
tifoid kepada manusia. Tifoid telah menyebabkan 11-20 juta orang sakit dan 
dianggarkan angka kematian mencecah antara 128 000 hingga 161 000 setiap tahun. 
Bakteria ini disebarkan melalui laluan mulut ke usus oleh  makanan atau minuman 
yang tercemar. Infeksi kebiasaannya berlaku pada pundi hempedu, hati, ileum, limpa 
dan sumsum tulang. Sehingga kini, pembuangan hempedu secara pembedahan 
melalui prosedur kolesistektomi merupakan pilihan efektif untuk pesakit pembawa 
tifoid yang mempunyai batu hempedu. Dalam kajian ini, lapan puluh (80) pesakit 
yang mendaftar untuk kolesistektomi dan mempunyai penyakit kehepatohempeduan 
adalah dipilih sebagai sampel. Satu kajian mudah telah dijalankan untuk 
memencilkan S. Typhi melalui empat teknik kultur; iaitu kultur terus (teknik 1), 
pengumpulan lapisan atas (teknik 2), vorteks (teknik 3) dan pengasingan supernatan 
dan pelet (teknik 4) sebelum melakukan PCR dan ujian serologi menggunakan ujian 
Typhidot-C. Daripada jumlah 80 sampel, lapan sampel (Gb9, Gb10, Gb11, Gb15, 
Gb43, Gb50, Gb64 and Gb74) menunjukkan kehadiran koloni yang disyaki spesis 
Salmonella di agar-agar HE dan agar-agar XLD dengan menggunakan teknik 
pengasingan supernatant dan pelet. Kesemua lapan sampel tersebut telah diuji 
dengan ujian biokimia yang terdiri daripada ujian triple sugar iron (TSI), ujian 
urease, ujian sitrat, ujian indol dan ujian  metil merah (MR). Keputusan 
xiv 
menunjukkan kesemua lapan sampel tersebut adalah negatif Salmonella. Ujian 
‘Electronic RapID Compendium (ERIC
TM
) telah dilakukan dan keputusan 
menunjukkan Citrobacter freundii telah dikesan dengan kebarangkalian 99 peratus. 
Daripada lapan sampel tersebut, enam sampel menunjukkan pengesanan negatif 
Salmonella oleh PCR, manakala dua sampel positif oleh PCR tetapi ujian biokimia 
menunjukkan kedua-dua sampel adalah negatif Salmonella. Ujian serologi 
menggunakan Typhidot-C telah dijalankan dan keputusan menunjukkan kesemua 37 
sampel darah adalah negatif pembawa S. Typhi. Sebagai kesimpulan, kajian ini tidak 
dapat memencilkan dan menghubungkan kehadiran S. Typhi daripada pesakit 
kehepatohempeduan di HUSM berbanding dengan negara yang endemik tifoid. 
Cadangan di masa akan datang, kriteria dalaman hendaklah diperhaluskan seperti 
merangkumi pesakit yang mempunyai sejarah tifoid, memperbesarkan saiz sampel 





















DETECTION OF Salmonella enterica subsp. enterica serovar Typhi FROM 
CHOLECYSTECTOMY SAMPLES BY CONVENTIONAL, SEROLOGICAL 




Salmonella enterica subsp. enterica serovar Typhi (S. Typhi) is an agent of 
typhoid in human. Typhoid has been reported causing 11-20 million people illnesses 
and estimated 128 000 to 161 000 deaths every year. The bacteria were spread by 
fecal-oral route through infected food or water. The most common sites of infection 
are the gallbladder, liver, ileum, spleen and bone marrow. At the moment, removal of 
the gallbladder through cholecystectomy procedure remains the effective option for 
typhoid carriers with gallstones. In this study, eighty (80) patients that enrolled for 
cholecystectomy and  having hepatobiliary disease were chosen as sample. A 
convenience study has been performed to isolate S. Typhi by using four culture 
techniques; which are direct incubation (technique 1), upper layer collection 
(technique 2), vortex (technique 3) and supernatant and pellet separation (technique 
4), then proceed to conventional polymerase chain reaction (PCR) test and serology 
test using Typhidot-C. Out of 80 samples, eight samples (Gb9, Gb10, Gb11, Gb15, 
Gb43, Gb50, Gb64 and Gb74) showed the presence of suspected colonies of 
Salmonella species on the Hektoen Enteric (HE) agar and Xylose Lysine 
Deoxycholate (XLD) agar by using supernatant and pellet separation technique. All 
eight sample of suspected colonies were tested with biochemical test which included 
triple sugar iron (TSI) test, urease test, citrate test, indole test and methyl red (MR) 
test. The result showed that all suspected colonies were negative for detection of 
Salmonella species. Electronic RapID Compendium (ERIC
TM
) test was done and 
xvi 
Citrobacter freundii was detected with probability of 99 per cent. From the eight 
samples mentioned, six samples were shown negative detection of Salmonella 
species by PCR, meanwhile, two samples were positive by PCR but both samples 
were negative for Salmonella by biochemical test. Serology test by using Typhidot-C 
were done and the result showed all 37 blood samples were negative for S. Typhi 
carrier. As a conclusion, this study not able to isolate and correlate the presence of 
the S. Typhi in HUSM patients with hepatobiliary diseases in comparison to other 
typhoid endemic countries. As for recommendation, there is a need to refine the 
inclusion criteria such as includes the patients that have typhoid history, increase the 








1.1 Research background   
Typhoid is a serious life-threatening worldwide public health problem caused by the 
Salmonella enterica subsp. enterica serovar Typhi (S. Typhi) that usually spread 
through contaminated food or water. Typhoid has been reported causing 11-20 
million people illnesses and estimated 128 000 to 161 000 deaths every year (WHO, 
2018). Typhoid causes significant mortality and morbidity especially in Asia, Africa, 
Middle East and Latin America (Ajibola et al., 2018). The incidence of typhoid 
differs within Asian continent examples India and Pakistan that have been reported 
to have high incidence rate of typhoid. (Ochiai et al., 2008).  
 
It has been estimated that around 2-5% of individuals who have been infected 
with S. Typhi has a possibility of becoming a chronic carrier without showing any 
symptoms after one year of infection. These chronic carriers are very infective due to 
the excretion of the S. Typhi in stool or urine, which thus helping to maintain the 
endemicity of the disease (Levine et al., 1982; Shpargel et al., 1985). Therefore, 
there is a need to detect the S. Typhi carrier in order to eliminate or reduce the 
typhoid burden. So far, there is no carriers detection available in the market and few 
are still at the evaluation stage. At the moment, isolation of the S. Typhi from the 
stool or urine are the most method applied to identify the carriers (World Health 
Organization, 2003) However,  isolation of the S. Typhi from the stool of carriers is 
difficult due to the intermittently low number of  shedded bacteria (Baker et al., 
2010).  
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 In 2003, the five-year Food and Water Borne Disease (FWBN) Plan of 
Action was launched which aim to reduce the incidence rate of typhoid in Kelantan. 
Typhoid patients were monitored with stool clearance at regular interval. By 2008, 
the incidence rate of typhoid in Kelantan was successfully reduced to 3.29/100,000 
population and further to 2.8/100,000 in 2010 (Hamzah et al., 2011). However, the 
case of typhoid is still ongoing. A study from Farooqui and colleague in 2009 have 
shown that untreated drinking water has increased the risk of infection since many 
people in Kelantan still used well water for domestic activities as the main water 
source. Moreover, an inadequate sanitary condition, especially in the rural area, also 
contributed to the increased rate of typhoid in Kelantan. This situation becomes 
worse with the chronic carriers are still intermittently release the S. Typhi.  
 
It has been reported that the development of chronic carriage often correlates 
with the biliary disease associated to the abnormalities of the gallbladder especially 
in the presence of gallstones (Lai et al., 1992). A study from Sharma and colleague 
in 2007 showed that chronic typhoid carriers in the endemic region represent around 
10% of patients with cholelithiasis and 30% of gallbladder carcinoma (Sharma et al., 
2007). In HUSM, cholecystectomy which is surgical removal of the gallbladder is an 
effective option for hepatobiliary patients, especially with gallstones. By taking this 
opportunity, this study was conducted to isolate S. Typhi from the cholecystectomy 
patients related hepatobiliary diseases in HUSM for carrier detection. 
 
 Meanwhile, serological tests have often been proposed as possible test for 
chronic carrier of S. Typhi. It because this tests are mostly cost effective, easy to 
handle and are free from the limitations of culture and other available methods since 
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the serum shows the status of a  longer period (Baker et al., 2010). A carrier 
screening test, Typhidot-C which used for detection of Immunoglobulin A (IgA) and 
Immunoglobulin G (IgG) antibodies toward the S. Typhi outer membrane protein. A 
study from Chua et al. (2015) have successfully detected all four chronic carrier and 
ten suspected carriers from food handler’s population by using Typhidot-C test. 
1.2 Rationale of study 
S. Typhi has developed mechanisms to survive and grow in the bile-rich environment 
(Lovane et al., 2016). A study from Freedman and Goldenberg (1962) has found that 
disease of the hepatobiliary system mostly associated with common bile duct 
obstruction closely related to bacterial infection. The bacteria can establish an 
infection in the human by colonizing the gallbladder and continue to survive with 
biofilm formation (Crawford et al., 2010). Meanwhile, the asymptomatic typhoid 
carrier in human showed no symptom and up to 5% of them shed the organisms for 
years.  Identification of the S. Typhi through stool culture remains a gold standard 
method, however finding the pathogen is difficult since the shedding of the pathogen 
is typically at the low level and intermittent especially for carriers (Crawford et al., 
2010). Besides, their adaptation in various environments makes the way harder to 
find them. Therefore, there is a need to find an alternative method to identify the 
carriers.     
 
A study from Dongol and colleague (2012) at Patan Hospital, Kathmandu, 
Nepal have found that S. Typhi can be isolated from bile samples in gallbladders of 
patients undergoing cholecystectomy. Mansour and colleague (2012) also 
successfully isolated the S. Typhi from Egyptian patients which diagnosed with 
chronic cholecystitis and acute chronic cholecystitis. However, previous study by 
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Monalis et. al (2008) suggested that toxicity of bile salts will affect the recovery of 
the organism in bile containing cultures. Here, modification of the gallbladder culture 
techniques is required in order to enhance the success rate of isolate S. Typhi from 
the gallbladder. Conventional ways to isolate the bacteria is by culture the specimen 
into the enriched media and incubated at 37°C with shaking condition. 
 
S. Typhi has been shown to be associated with hepatobiliary disease and in 
Hospital USM, cholecystectomy is the most common method for handling patients 
with hepatobiliary diseases with two to three patients were continuously doing 
cholecystectomy every week in the surgery department. With a strong justification 
and statistic on Kelantan has the highest incidence of typhoid in 2015, this study 
hypothesized that patients with hepatobiliary disease-carrying of the S. Typhi are 
high.  In the recent technique, only stool culture and polymerase chain reaction 
(PCR) were done to isolate and detect S. Typhi. However, isolation of S. Typhi is 
difficult due to the intermittently shedding of the organism. Since gallbladder was 
reported to become a niche for S. Typhi, a modification method is needed to culture 
bile, tissue and stones from the gallbladder (Gonzalez-Escobedo and Gunn, 2013). 
Therefore, this study was focusing on isolating and identification of S. Typhi from 
the hepatobiliary patients’ gallbladder using PCR, serology test by using patient’s 




1. To identify the presence of S. Typhi from gallbladder culture using four 
different techniques of optimization; direct incubation, upper layer collection, 
vortex and supernatant and pellet separation.  
2. To detect S. Typhi from the patient with hepatobiliary disease using 
Polymerase Chain Reaction (PCR). 









2.1  Typhoid fever                  
Typhoid is a systemic infection characterized by a fever caused by the S. Typhi 
(Waddington et al., 2014). Typhoid is transmitted by a fecal-oral route through 
infected food or water. The pathogen penetrates the gastrointestinal mucosa, 
duplicates within macrophage, and spread via the bloodstream to the gallbladder,  
bone marrow, intestinal lymph nodes, liver and spleen (Charles et al., 2013). The 
most common sites of infection are the gallbladder, liver, ileum, spleen and bone 
marrow (Gonzalez-Escobedo et al., 2011). Furthermore, this pathogen can survive 
for days in a normal environment such as in a well, and months in infected eggs and 
frozen oysters (Bhan et al., 2005). They may also survive in acid foods and resist 
dehydration. This means that it is difficult to eradicate the bacteria.  
2.2 General background on Salmonella                    
Salmonella is gram-negative bacteria that cause enteric disease in animals and 
human. Salmonella was early discovered and isolated by Theobald Smith in 1855, 
from intestines of pigs which infected by swine fever (Eng et al., 2015). Later, 
French bacteriologist Joseph Leon Marcel Lignieres proposed that the group of 
bacteria represented by the swine-cholera should be named as ‘Salmonella’ as 
credited to an American pathologist, Dr. Danial Elmer Salmon (Eng et al., 2015).  
 
The nomenclature of Salmonella is complicated and still evolves from initial 
one serotype-on species concept proposed by Kauffmann (1966) which based on the 
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serologic identification of O (somatic) antigen and H (flagellar) antigen. Currently, 
the Centers for Disease Control and Prevention (CDC) use the nomenclature system 
of Salmonella recommended by the World Health Organization (WHO) 
Collaborating Centre (Popoff et al., 2003).  
 
According to the system, the genus Salmonella is classified into two species, 
Salmonella enterica (type species) and Salmonella bongori, based on its differences 
in their 16S rRNA sequence analysis. S. enterica can be further categorized into six 
subspecies which denoted with Roman numerals; l, S. enterica subsp. enterica; ll, S. 
enterica subsp. salamae; llla, S. enterica subsp. arizonae; lllb, S. enterica subsp. 
diarizonae; lV, S. enterica subsp. hountenae; Vl, S. enterica subsp. indica. Almost 
99% of Salmonella found in human and warm-blooded animals are from group l S. 
enterica subsp. enterica. While other subspecies and S. bongori rarely found in 
human but often found in the environment and cold-blooded animals (Eng et al., 
2015).  
 
The species Salmonella enterica comprises over 2 500 serovars, which are 
classified by the flagellar and lipopolysaccharide (LPS) antigens, and it includes both 
typhoidal and non-typhoidal Salmonella strain. Salmonella enterica subsp. enterica 
serovars Typhi (S. Typhi) together with other salmonella serovars such as Paratyphi 
are restricted human pathogens that cause the systemic disease and abdominal pain 
(LaRock et al., 2015).  
 
Diarrhea is a more common symptom in children infected with Salmonella, 
while for the people with immunosuppression is likely to develop constipation 
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(Thielman and Guerrant, 2004). Typhoid shows a specific pattern of fever with initial 
low-grade fever and slowly develops to high-grade fever in the second week. If 
untreated, the fever can carry on up to a month and more (Patel et al., 2010).  The 
typhoid incidence is highest in regions that have poor sanitation and a further 
increase during the dry and hot season due to the high concentration of the bacteria in 
a limited amount of water (Crum, 2003). Study results from the International 
Vaccine Institute in Korea have shown variation in the distribution of typhoid fever 
from sites in five Asian Countries by using standardized surveillance, clinical and 
microbiological procedures as shown in Table 1 from August 2002 till July 2004. 
Consumption of water at labor site (Luby et al., 1998), drinking from contaminated 
tap water (King et al., 1989) and using non-boiled untreated spring water 
(Swaddiwudhipong, 2001) can lead to typhoid infection. 
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Table 2.1 Surveillance data of typhoid fever from sites in five Asian countries        
from August 2002 till July 2004.  
(Adapted from John Wain   et al. (2015)). 
  
  
 Site The incidence of typhoid fever 
China Urban and rural 15.3 cases per 100 000 per year in people aged 
5-60 years old 
Vietnam Urban 24.2 cases per 100 000 per year in people aged 
6-18 years old 
Indonesia Urban slum 81.7 cases per 100 000 per year (all years) 
Pakistan Urban slum 451.7 cases per 100 000 per year in children 
aged 2-15 years 
India Urban slum 493.5 cases per 100 000 per year (all ages) 
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2.3 Typhoid in Malaysia 
In Malaysia, typhoid is one of the major infectious diseases related to food and 
waterborne disease. Figure 2.1 showed the geographical distribution of typhoid in 
Malaysia with high incident rate of more than 100 per 100 000 per population. In 
2008,  201 cases of typhoid were reported and before that, in 2005, 735 cases and 2 
deaths have been reported occurred in Kelantan (MOH, 2008). Table 2.2 showed 
Kelantan and Selangor are the most infected state in Peninsular, while Sabah remains 
reported the highest case in Malaysia in 2010 (MOH, 2011). 
 
 Kelantan has been reported endemic for typhoid (Goay et al., 2013). Malik 
and Malik (2001) reported from the Ministry of Health Malaysia that the ‘highest 
number of typhoid cases was in 1998 and 1999 which was from Kelantan and the 
majority were children’.  Meanwhile, Choo et al. (1988) reported that patients 
admitted to Hospital Universiti Sains Malaysia (HUSM) for typhoid with the average 
age was 7.3 years old, which is comparable to Malik and Malik (2001) who stated 
7.5 years old from the same hospital. However, these data contrasted with the study 
by Levine et al (1982) which stated that in Santiago, Chile, most of the infected 
patients were forty years old and above. 
 
From 2011, the incidence rate of typhoid fever in Malaysia shown decreases 
number from 1.71 per 100,000 population to 0.70 per 100,000 population in 2014 
(Figure 2.2). However, in 2015 the incidence has increased to 1.42 per 100,000 
population. In comparison with other states, Kelantan has been reported to have a 
higher incidence of typhoid cases compared to the other states in Malaysia (Baddam 
et al., 2012). In 2015, the cases of typhoid in Kelantan have increased to 35 cases 
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when compared to year 2014. Meanwhile, the incidence rate of typhoid in Kelantan 
has increased up to 10.6 per 100 000 population, which was 10 times above national 
level and median five years incidence rate (Akhir et al., 2018). 
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Figure 2.1: Map above shows the geographical distribution of typhoid. Malaysia is 
shown to have a higher incident rate of typhoid with more than 100 per 
100 000 per population. Adapted from Crump et. al (2004).  
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Table. 2.2 Incidence rate per 100,000 population and the number of typhoid 
cases by states in Malaysia, year 2010.  
 
State Incidence rate 
(per 100 000) 
Number of cases 
Kedah 0.1 2 
Pulau Pinang 0.1 2 
Negeri Sembilan 0.2 2 
Pahang 0.2 3 
Perak 0.2 5 
Sarawak 0.2 5 
Johor 0.4 13 
Terengganu 0.4 4 
Selangor 0.6 33 
Kuala Lumpur 0.7 12 
Perlis 0.9 2 
Sabah 2.5 80 
Kelantan 3.0 46 












2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Malaysia 4.1 0.8 1.2 0.7 1.07 0.74 1.71 1.58 0.73 0.7 1.42
Kelantan 56.7 4.64 8.52 3.29 4.7 2.8 5 1.8 2.5 2.1 0
Incidence Rate of Typhoid per 100,000 population in Malaysia and Kelantan 
2.5 2.1 NA 
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2.4 Detection of S. Typhi for acute and carriers  
There are several methods to isolate and detect the S. Typhi: bacterial culture; 
serological test; and polymerase chain reaction (PCR) (Wain and Hosoglu, 2008; 
Chua et al., 2015). Culture remains the most effective method in diagnosing the 
typhoid fever. However, it may lack sensitivity and speed due to the culture results 
will produce within 2-7 days. As for the negative culture, the result will easily 
interpret with no colonies growth or nonsuspected colonies growth after overnight 
cultured on the agar plate (Ismail, 2000a).  
 
2.4.1 Bacterial culture 
2.4.1(a) Blood culture 
Sensitivity of blood culture is variable between 40% and 60%, in contrast with the 
sensitivity of bone marrow aspirate cultures which is more than 80% (Gilman et al., 
1975; Baker et al., 2010). However, in countries with limited resources, diagnosis for 
blood cultures or bone marrow aspirate for typhoid fever could not be done due to 
the limited skill personnel and high expense (Farooqui et al., 1991).  
 
2.4.1(b) Stool Culture 
In low-resource setting area, stool culture is commonly used in most diagnostic 
laboratories (Ajibola et al., 2018). Stool sample should be collected in sterile wide-
mouthed containers and inoculated within two hours of collection or stored at 4°C 
until ready to inoculate. Even though stool culture is the gold standard for diagnosing 
typhoid fever, some of the challenges in isolating S. Typhi such as time consuming, 




2.4.2 Molecular Detection 
Development of molecular tests for typhoid diagnosis involves genetic markers that 
are specific and sensitive for detection of bacterial DNA (Goay et al., 2016). Nucleic 
acid amplification tests, including conventional polymerase chain reaction (PCR), 
multiplex, nested and real-time PCR, has been established for the detection of S. 
Typhi in blood (Song et al., 1993; Wain et al., 1998; Ali et al., 2009; Baker et al., 
2010).  
  
PCR is used to diagnose typhoid fever by using the flagellin gene because its 
hypervariable region Vi is unique for S. Typhi and its amplification provides 100%  
specificity (Song et al., 1993; Frankel, 1994). However, application of molecular 
techniques in clinical settings has technical limitations because of the few number of 
bacteria in blood, approximately 0.5 CFU/ml (Wain et al., 1998). Previous study has 
shown to overcome the low sensitivities of samples, PCR test has been developed 
with some pre-enrichment step in culture in order to improve sensitivity and to 
reduce PCR inhibitors (Chiu and Ou, 1996). However, these test still be influenced 
by the adequate concentration of DNA within the detection limit being presented in a 
sample specimen tested (Chua et al., 2015).   
 
2.4.3 Serological test  
The Widal test was established by Georges Ferdinand Widal in 1896. This test helps 
to identify the presence of Salmonella antibodies in serum of patients by measures 
agglutinating antibodies against the O (somatic) antigen and H (flagellar) antigens of 
S. Typhi in people sera with suspected with typhoid fever. Agglutination reaction 
proposed a positive result, while an absence of agglutination proposed a negative 
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result. The Widal test is simple, cost effective and widely used in developing 
countries. However, these test only useful for diagnosis of acute typhoid fever and 
defective in endemic areas  (Pang and Puthucheary, 1983).  
 
The Vi capsular antigen of S. Typhi is used as a screening tool for typhoid 
carriers since they frequently produce higher levels of antibody compared to acute 
patients (Lanata et al., 1983). However, the Vi capsule is known to be less 
immunogenic than other antigens since the importance of Vi antigen for immune 
evasion and invasion in various studies has been established (Raffatellu et al., 2006).  
 
Previous study has demonstrated that the 50 kDa of the outer membrane 
protein of S. Typhi antigenically specific for S. Typhi (Ismail et al., 1991). A rapid 
dot enzyme immunosorbent assay (EIA) method was developed based on the 50 kDa 
which detects immunoglobin (Ig) M and IgG antibodies toward the 50 kDa antigen in 
human sera (Ismail et al., 1991). Evaluation of the tests in clinical settings, have 
showed the dot EIA test (Typhidot) offers simplicity, specificity (75%), sensitivity 
(95%), speed (1-3 hours) and with high positive and negative predictive values 
(Choo et al., 1994). However, the IgM detection only suitable for acute cases while 
IgG result cannot differentiate between acute and convalescent cases due to the IgG 
persist for more than two years in patients infected with typhoid fever (Choo et al., 
1997). 
 
Typhidot-M is a modification test from Typhidot which demonstrated the 
inactivation of IgG and allow accessibility of the antigen to the specific IgM. The 
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detection of specific IgM within three hours would suggest acute typhoid infection 
(Ismail, 2000b).  
 
 
2.5 Characteristics of S. Typhi 
2.5.1 Morphological characteristics 
Salmonella are rod-shaped bacteria with 2-3 µm long and 0.4-0.6 µm diameter. S. 
Typhi belongs to the Enterobacteriaceae family, Gram-negative bacteria that have 
flagellated bacilli and facultatively anaerobe (Khan et al., 2008). 
 
2.5.2 Culture characteristics 
The common selective agar used are MacConkey, Hektoen enteric (HE), Xylose 
lysine deoxycholate (XLD), Deoxycholate citrate agar (DCA) and Salmonella-
Shigella (SS) agar which incubated at 37°C for 18-24 hours (World Health 
Organization, 2003). Salmonella produce lactose non-fermenting colonies on lactose 
enriched media such as MacConkey agar, deoxycholate agar and SS agar.  
 
On the HE agar, Salmonella produce transparent green colonies with a black 
dot in the centers. While on the XLD agar, Salmonella produce transparent red 
colonies with a black dot in the centers. The black dot in the centers represents the 
presence of hydrogen sulphide (H₂S) (World Health Organization, 2003). Table 2.3 
shows the colonies characteristics of Salmonella serovars/ S. Typhi. 
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Table 2.3: Colonies characteristics of Salmonella serovars/ S. Typhi.  
 
(Adapted from WHO, 2003). 
 
Media Salmonella serovars/ S. enterica ser. enterica Typhi 
MacConkey agar Non-lactose fermenter with smooth colourless colonies 
HE agar Transparent green colonies with black dot in the centers 
XLD agar Transparent red colonies with black dot in the centers 
DCA Non-lactose fermenter with black dot in the centers 
SS agar Non-lactose fermenter with black dot in the centers 
Blood agar 
 
Non-haemolytic smooth white colonies 
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2.5.3 Biochemical and serological characteristic 
There are well-established confirmation and identification procedures for Salmonella 
spp. after preliminary identification on colony appearance on selective agar media. 
The colony will further analyse using classical biochemical and serological testing. 
Key biochemical tests are fermentation of glucose. As for S. Typhi, the bacteria 
produce hydrogen sulphide in triple-sugar (TSI) iron agar slant with negative 
reaction for urease, Simmon’s citrate and indole test. Table 2.4 shows the result of 
biochemical identification of Salmonella serovars and Enterobacteriaceae family. 
Serological confirmation tests typically use polyvalent antisera for flagellar (H) and 
somatic (O) antigens. Isolates with the typical biochemical profile, which agglutinate 
with both H and O antisera are usually used to identify Salmonella spp.
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Table 2.4: Biochemical identification among Enterobacteriacae family (WHO, 2003). 
 
Organism Triple-sugar iron (TSI) Motility Indole Urea Citrate  




1. S. enterica ser. enterica 
Typhi 
Alk Acid Weak - + - - - 
2. S. enterica ser. enterica 
Parayphi A 
Alk Acid - + + - - - 
3. Salmonella spp. Alk Acid V V + - - V 
4. Escherichia coli Acid Acid - + + + - - 
5. Klebsiella spp. Acid Acid - ++ - V + + 
6. Citrobacter spp. V Acid +++ + + V - + 
7. Proteus spp. Alk Acid + + + V ++ V 
 
The production of acid makes the agar turn to yellow. The slant section is for detection of lactose fermentation meanwhile butt section is 
for glucose fermentation. 
 
Alk = alkaline, V = variable result 
‘+’ = positive result and ‘-’ = negative result
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2.6 Typhoid carrier 
WHO defined a carrier who continues to excrete S. Typhi for more than one year 
after infected with typhoid. Approximately  2-5 %  of typhoid patients fail to clear 
the infection hence become chronic carriers of S. Typhi (Levine et al., 1982). These 
carriers are most difficult to diagnose and the condition is further complicated with 
carriers are asymptomatic (Mortimer, 1999) and  almost 25% of carriers experience 
no clinical history of typhoid (Parry et al., 2002). Therefore, their recognition and 
treatment constitute a serious public health problem due to the continuously 
spreading of the disease. Moreover, since S. Typhi is a human-specific pathogen, 
these carriers form a crucial reservoir for the spread of the disease by shedding the 
pathogen through urine and feces (Bhan et al., 2005).  
 
 The most popular case of typhoid fever is reported as Typhoid Mary case. 
Mary Mallon, an immigrant cook, who first caused the spread of fever in New York. 
She was quarantined in a cottage at Riverside Hospital after had a positive result for 
S. Typhi (Soper, 1939). In 1910, she was released with the condition that she never 
becomes a cook. However, she broke the promise and worked as a cooker at Sloane 
Maternity in Manhattan. In three months, 25 people were identified infected with the 
S. Typhi and two of them died. She was placed back in North Brother Island and 
remained there until death. 
 
2.6.1 Gallbladder disease 
Cholecystitis is caused by obstruction of the biliary tract due to the gallstones 
existing in the gallbladder which causes bile stasis, distention, inflammation and 
infection of the gallbladder (Swidsinski and Lee, 2001).  
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 Other study showed that approximately 90% of chronic carriers have 
gallstones in the gallbladder (Shioler et al., 1983; Karaki, 1984) and S. Typhi more 
preferred to form the biofilm on cholesterol gallstones compared to pigmented stones 
(Crawford et al., 2008).  
 
2.6.2 Association of gallbladder disease with S. Typhi 
A study from Dongol and colleague (2012) at Patan Hospital, Kathmandu, Nepal 
have found that S. Typhi can be isolated from bile samples in gallbladders of patients 
undergoing cholecystectomy. Out of 1,377 patients underwent cholecystectomy, 274 
bile samples were Gram-negative organism isolated included E. Coli, Klebseilla spp., 
Pseudomonas spp., Acinetobacter spp., Enterobacter spp., Citrobacter freundii, 
Vibrio spp. and Serratia marcescens and 24 of them were S. Typhi.  
 
Out of 48 patients of Salmonella bile-positive, only seven patients had a 
memorable history of typhoid, which none of them were confirmed by 
microbiological culture. Other researchers such as Mansour and colleague (2012) 
also successfully isolated the S. Typhi from Egyptian patients which diagnosed with 
chronic cholecystitis and acute chronic cholecystitis. Out of 257 patients, S. Typhi 
was successfully isolated from 28 samples of gallstones, 12 samples of gallbladder 
epithelial tissues and 4 samples of bile. Meanwhile, from the 28 samples of 





2.6.4 Adaptation of Salmonella to bile 
Bile is a body fluid containing bile salts, fatty acids, cholesterol and variety of 
protein and electrolytes (Hernandez et al., 2012). Bile helps in the breakdown of fats, 
removal of excess cholesterol in the liver and helps absorption of fat-soluble 
vitamins in intestines (Hoffman, 1998). Bile salts consist of 61% of the bile 
composition, followed by 12% fatty acids, 9%  cholesterol, 7%  proteins, 3%  
phospholipids and bilirubin, and 5%  from inorganic salts such as potassium, sodium 
and bicarbonate (Kristiansen et al., 2007).  
 
 Bile also acts as bactericidal agent following with hydrochloric acid and 
gastric secretions which found in the digestive system. Bile salts in bile have been 
found to protect against pathogenic bacteria besides helping in the digestion of fatty 
acid (Merritt and Donaldson, 2009). For example, a patient that having cirrhosis of 
the liver, bacterial overgrowth is detected in the small intestine due to the less bile is 
secreted (Ding et al., 1993). Meanwhile, in the small intestine, only a few bacteria 
were harboured due to the contain of high amount of bile (Inagaki et al., 2006). 
 
 Although bile containing high bile salts, some bacterial species are resistant 
to it activities (Begley et al., 2005). Salmonella enterica is one of the examples of the 
bile-resistant pathogen. This pathogen colonizes the hepatobiliary tract throughout 
systemic infection and continues to live in gallbladder during chronic infection 
(Gonzales-Escobedo et al., 2011). This bile resistance is caused by the presence of a 
glycolipid, the enterobacterial common antigen, found in the outer membrane of 
Enterobacteriaceae (Ramos-Morales et al., 2003). 
 
